Bloomington, Indiana — According to state and local economic development sources Catalent Pharma Solutions plans to invest $350,000,000.00 to build out new space in Bloomington. The company plans to occupy the new space at 1300 S Patterson Dr. in Bloomington, on or about October 1, 2023. According to the company website Catalent Inc. (NYSE: CTLT), an S&P 500 company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown to become a community of approximately 19,000+ employees who support over 7,000 products for over 1,000 customers around the world. We share a common goal: to put patients first and help people around the world live better and healthier lives. Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. We have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging results.

To learn more about Catalent Pharma Solutions, visit http://www.catalent.com/

Company Contact:
John Chiminski, Chief Executive Officer
john.chiminski@catalent.com
https://www.linkedin.com/in/johnchiminski/
877-587-1835

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved